TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Desitin Pharma AB
Closing information (x1000 SEK)
Closing information | 2024/09 | 2023/09 | 2022/09 |
Turnover |
8,178
|
11,374 | |
Financial expenses |
0
|
42 | |
Earnings before taxes |
819
|
1,389 | |
EBITDA |
818
|
1,431 | |
Total assets |
9,217
|
5,843 | |
Current assets |
9,217
|
5,843 | |
Current liabilities |
4,808
|
1,223 | |
Equity capital |
4,409
|
4,620 | |
- share capital |
100
![]() |
100 | |
Employees (average) |
1
|
2
|
3 |
Financial ratios
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Solvency |
47.8%
|
79.1% | |
Turnover per employee |
4,089
|
3,791 | |
Profit as a percentage of turnover |
10.0%
|
12.2% | |
Return on assets (ROA) |
8.9%
|
24.5% | |
Current ratio |
191.7%
|
477.8% | |
Return on equity (ROE) |
18.6%
|
30.1% | |
Change turnover |
-3,196
|
-645 | |
Change turnover % |
-27%
|
-28%
|
-5% |
Chg. No. of employees |
-1
![]() |
-1
|
0 |
Chg. No. of employees % |
-50%
|
-33%
|
0% |
Total value of public sale
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.